{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:59:22Z","timestamp":1766145562319,"version":"3.48.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bcmd.2025.102965","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:44:47Z","timestamp":1761403487000},"page":"102965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B"],"prefix":"10.1016","volume":"116","author":[{"given":"Wenjue","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcmd.2025.102965_bb0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMc2415164","article-title":"Platelet-targeted gene therapy for Hemophilia A with inhibitor history","volume":"392","author":"Eapen","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcmd.2025.102965_bb0010","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI28416","article-title":"Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bcmd.2025.102965_bb0015","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2025.102965_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.375","article-title":"Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2025.102965_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/bmb\/ldad017","article-title":"Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation","volume":"147","author":"Canarutto","year":"2023","journal-title":"Br. Med. Bull."},{"issue":"9","key":"10.1016\/j.bcmd.2025.102965_bb0030","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1182\/blood-2005-09-3593","article-title":"Mobilization as a preparative regimen for hematopoietic stem cell transplantation","volume":"107","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102965_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.omtm.2019.11.013","article-title":"Non-toxic HSC transplantation-based macrophage\/microglia-mediated GDNF delivery for Parkinson\u2019s disease","volume":"17","author":"Chen","year":"2020","journal-title":"Molec. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.bcmd.2025.102965_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13110","article-title":"Mobilization-based transplantation of young-donor hematopoietic stem cells extends lifespan in mice","volume":"19","author":"Guderyon","year":"2020","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.bcmd.2025.102965_bb0045","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41375-018-0200-3","article-title":"A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells","volume":"32","author":"Du","year":"2018","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.bcmd.2025.102965_bb0050","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","article-title":"Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells","volume":"185","author":"Omer-Javed","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2025.102965_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-943-3_1","article-title":"Mobilization of hematopoietic stem\/progenitor cells: general principles and molecular mechanisms","volume":"904","author":"Bonig","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"14","key":"10.1016\/j.bcmd.2025.102965_bb0060","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2016-11-752923","article-title":"Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice","volume":"129","author":"Bernitz","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcmd.2025.102965_bb0065","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/leu.2012.17","article-title":"Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or plerixafor have distinct mechanisms of action on bone marrow HSC niches and bone formation","volume":"26","author":"Winkler","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bcmd.2025.102965_bb0070","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcmd.2025.102965_bb0075","article-title":"Molecular signatures of proliferation and quiescence in hematopoietic stem cells","volume":"2","author":"Bing","year":"2004","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.bcmd.2025.102965_bb0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.20131072","article-title":"Improved HSC reconstitution and protection from inflammatory stress and chemotherapy in mice lacking granzyme B","volume":"211","author":"Carnevalli","year":"2014","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.bcmd.2025.102965_bb0085","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20010916","article-title":"Changes in the proliferative activity of human hematopoietic stem cells in NOD\/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors","volume":"196","author":"Cashman","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2025.102965_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2024.104281","article-title":"Mobilization dynamics of bone marrow hematopoietic stem cells during hematopoietic regeneration","volume":"138","author":"Johansson","year":"2024","journal-title":"Exp. Hematol."},{"issue":"10","key":"10.1016\/j.bcmd.2025.102965_bb0095","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1182\/blood.V81.10.2566.2566","article-title":"Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice [see comments]","volume":"81","author":"Stewart","year":"1993","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bcmd.2025.102965_bb0100","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1210\/en.2016-1418","article-title":"A murine 5-fluorouracil-based submyeloablation model for the study of bone marrow-derived cell trafficking in reproduction","volume":"157","author":"Tal","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcmd.2025.102965_bb0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bjh.17867","article-title":"Identification of the minimum requirements for successful haematopoietic stem cell transplantation","volume":"196","author":"Nishi","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102965_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2020.09.192","article-title":"Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment","volume":"91","author":"Chen","year":"2020","journal-title":"Exp. Hematol."},{"issue":"17","key":"10.1016\/j.bcmd.2025.102965_bb0115","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2025.102965_bb0120","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V92.6.1950","article-title":"Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents","volume":"92","author":"van Os","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcmd.2025.102965_bb0125","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.V97.8.2278","article-title":"Cyclophosphamide\/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle","volume":"97","author":"Wright","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcmd.2025.102965_bb0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bmt.2015.58","article-title":"Leukemia cell mobilization with G-CSF plus plerixafor during busulfan\u2013fludarabine conditioning for allogeneic stem cell transplantation","volume":"50","author":"Konopleva","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.bcmd.2025.102965_bb0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon\u2013dependent exhaustion","volume":"15","author":"Sato","year":"2009","journal-title":"Nat. Med."},{"issue":"7240","key":"10.1016\/j.bcmd.2025.102965_bb0140","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFN\u03b1 activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"issue":"9\u201310","key":"10.1016\/j.bcmd.2025.102965_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/hum.2020.309","article-title":"Treatment of a Hemophilia B mouse model with platelet-targeted expression of Factor IX Padua","volume":"32","author":"Li","year":"2021","journal-title":"Hum. Gene Ther."},{"issue":"19","key":"10.1016\/j.bcmd.2025.102965_bb0150","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/bloodadvances.2023010088","article-title":"Murine erythroid differentiation kinetics in vivo under normal and anemic stress conditions","volume":"7","author":"Myers","year":"2023","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.bcmd.2025.102965_bb0155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V78.5.1237.1237","article-title":"Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil","volume":"78","author":"Harrison","year":"1991","journal-title":"Blood"},{"issue":"7648","key":"10.1016\/j.bcmd.2025.102965_bb0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature21693","article-title":"Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis","volume":"544","author":"H\u00e9rault","year":"2017","journal-title":"Nature"},{"issue":"7755","key":"10.1016\/j.bcmd.2025.102965_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcmd.2025.102965_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02982554","article-title":"Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts","volume":"74","author":"D\u2019Hondt","year":"2001","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2025.102965_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/15258160260090942","article-title":"Engraftment of post 5-fluorouracil murine marrow into minimally myeloablated (100 cGy) murine hosts","volume":"11","author":"D\u2019Hondt","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"issue":"16","key":"10.1016\/j.bcmd.2025.102965_bb0180","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/blood-2013-03-489641","article-title":"The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation","volume":"122","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102965_bb0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2024.04.225","article-title":"iNOS regulates hematopoietic stem and progenitor cells via mitochondrial signaling and is critical for bone marrow regeneration","volume":"219","author":"Sinha","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcmd.2025.102965_bb0190","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1634\/stemcells.2006-0808","article-title":"Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells","volume":"25","author":"Barese","year":"2007","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.bcmd.2025.102965_bb0195","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbmt.2018.03.006","article-title":"A conditioning regimen with plerixafor is safe and improves the outcome of TCR\u03b1\u03b2+ and CD19+ cell-depleted stem cell transplantation in patients with Wiskott-Aldrich Syndrome","volume":"24","author":"Balashov","year":"2018","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979625000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979625000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:56:56Z","timestamp":1766145416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979625000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S1079979625000579"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2025.102965","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2025.102965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102965"}}